Ignite Creation Date:
2025-12-24 @ 12:12 PM
Ignite Modification Date:
2026-01-09 @ 2:49 AM
Study NCT ID:
NCT00037661
Status:
COMPLETED
Last Update Posted:
2015-10-02
First Post:
2002-05-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Study Overview
Official Title:
Double-Masked, Randomized, Placebo-Controlled Study of Efficacy Parameter Following Administration of INS365 Ophthalmic Solution or Placebo in a Controlled Adverse Environment (CAE) Chamber in Subjects With Non-Sjogren's Associated Dry Eye
Status:
COMPLETED
Status Verified Date:
2015-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Comparative efficacy trial of INS365 Ophthalmic Solution and placebo in patients with dry eye.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: